-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
NITD-2
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/1197896-79-92d.gif)
| Category | Dengue virus |
| CAS | 1197896-79-9 |
| Description | NITD-2 is a DENV polymerase inhibitor that inhibits DENV RdRp protein mediated RNA elongation. It has poor cell membrane penetration. |
Product Information
| Synonyms | NITD-2;1197896-79-9;CHEMBL583412;2-[3-(1-Benzyl-1H-pyrazol-3-yl)-benzenesulfonylamino]-benzoic acid;BDBM50300193;AKOS040759563;DA-66111;MS-27744;HY-134665;CS-0147086;G18146;2-[3-(1-benzylpyrazol-4-yl)benzenesulfonamido]benzoic acid;2-[[3-(1-benzylpyrazol-4-yl)phenyl]sulfonylamino]benzoic acid; |
| IUPAC Name | 2-[[3-(1-benzylpyrazol-4-yl)phenyl]sulfonylamino]benzoic acid |
| Molecular Weight | 433.48 |
| Molecular Formula | C23H19N3O4S |
| Canonical SMILES | O=C(O)C1=CC=CC=C1NS(=O)(C2=CC=CC(C3=CN(CC4=CC=CC=C4)N=C3)=C2)=O |
| InChI | InChI=1S/C23H19N3O4S/c27-23(28)21-11-4-5-12-22(21)25-31(29,30)20-10-6-9-18(13-20)19-14-24-26(16-19)15-17-7-2-1-3-8-17/h1-14,16,25H,15H2,(H,27,28) |
| InChIKey | PHQOBFYGHBBCBV-UHFFFAOYSA-N |
| Boiling Point | 699.7±65.0°C at 760 mmHg |
| Purity | ≥95% |
| Density | 1.3±0.1 g/cm3 |
| Solubility | Soluble in DMSO |
| Appearance | Solid |